Navigation Links
Campbell Alliance Managed Markets Practice to Take Leadership Role at CBI's Formulary and Reimbursement Conference
Date:9/26/2007

RALEIGH, N.C., Sept. 26 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industries, today announced that its Managed Markets practice will be taking a leadership role at the 4th Annual Forum on Formulary and Reimbursement Strategies hosted by the Center for Business Intelligence (CBI). The conference will be held on September 27-28 at the Crown Plaza Valley Forge in King of Prussia, Pennsylvania.

Tony Lanzone, a Vice President at Campbell Alliance, will serve as conference chairperson. Mr. Lanzone has more than 15 years of experience in the healthcare industry, ranging from sales at a top-five pharmaceutical company to management consulting in both the hospital and pharmaceutical sectors. Prior to joining Campbell Alliance, he served as a senior director in Premier's HealthCare Informatics division. Mr. Lanzone earned his MBA from the Graduate School of Business at the College of William & Mary.

In addition, Mr. Lanzone and Steve Carter, Vice President in the Managed Markets practice at Campbell Alliance, will be facilitating a pre-conference workshop titled "Developing a Pricing and Reimbursement Strategy in an Evolving Payer Environment." Their presentation will focus on the importance of understanding the evolving reimbursement environment, and will provide an overview of payers and the role they play in the buying process for pharmaceuticals. The workshop will also review the key components of developing and executing strong payer strategies, including the potential product- and market-specific elements of a payer value proposition. During the workshop, participants will collaborate to develop an actual value proposition, contracting strategy, and pricing strategy in an interactive case study format.

Mr. Carter has provided consulting services to top pharmaceutical clients for more than a decade. His areas of expertise include pricing and contracting strategy, competitive assessment, research design, and analytical modeling. He holds a BS degree in Economics from the Massachusetts Institute of Technology.

For more information on CBI's Forum on Formulary and Reimbursement Strategies, please visit http://www.cbinet.com/show_conference.cfm?confCode=PC07074

About the Managed Markets Practice at Campbell Alliance

The Managed Markets practice at Campbell Alliance helps clients stay informed about changing conditions affecting the reimbursement and access landscape, understand the implications of these trends, and deal more effectively with third-party payers. Services include:

-- Market assessments utilizing quantitative and qualitative research and

analysis as well as decision-support modeling and scenario planning

-- Strategy development for key managed markets channels such as the

creation of value propositions and pricing and contracting strategies

-- Tactical execution including account segmentation and prioritization

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries. The firm's clients include most of the world's top 20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, and Sales. From its locations in Raleigh, N.C., Parsippany, N.J., Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, and Atlanta, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.

James Forte

Director, Public and Media Relations

Campbell Alliance

919-844-7100, extension 7195

jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Biomedical Alliance about more than stem cells
2. Doyle seeks $2.5M for biomedical alliance
3. Alliance looks to create the right chemistry in SE Wisconsin
4. Biomedical alliance marks first full year
5. New alliance to provide Wi-Fi network for City of Madison
6. Budget axe could cut SE Wisconsin tech alliance funding
7. Biotech Alliance pushes ahead in SE Wisconsin with likely state funding
8. Milwaukee research alliance sees need for incubator
9. University alliance gets $2.5 million to encourage minorities in science and technology
10. Suite Scheduler Announces Alliance with Ice Technologies
11. Alliance Brings E-Business Technologies to Wisconsin Manufacturers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2016  The Multiple Myeloma Research Foundation (MMRF) today ... Study SM —the largest and most comprehensive study driving ... myeloma—will be presented at the 58 th American ... San Diego from December 3-6. ... as well as identify pathways and targets for new ...
(Date:12/2/2016)... ... 2016 , ... ACEA Biosciences, Inc. announced today that it will be presenting ... the World Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. ... trials for AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR ...
(Date:12/2/2016)... York, NY (PRWEB) , ... December 01, 2016 , ... ... event is expanding to three days and will take place on February 1-3, 2017 ... (GSK) and Dr James Gulley (NCI), the program provides a unique 360-degree approach, which ...
(Date:12/2/2016)... MA (PRWEB) , ... December 02, 2016 , ... Robots ... Light Event on December 3rd, 2016. The event, which is held on the ... work with helping Americans with Disabilities back into the workplace. Suitable Technologies is partnering ...
Breaking Biology Technology:
(Date:11/17/2016)... INDUSTRY, Calif. , Nov. 17, 2016  AIC announces that it has just ... servers in organizations that require high-performance scale-out plus high speed data transfer storage solutions. ... ... ... Setting up a ...
(Date:11/15/2016)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... gut microbiome, today announced the pricing of an ... common stock and warrants to purchase 50,000,000 shares ... the public of $1.00 per share and accompanying ... offering, excluding the proceeds, if any from the ...
(Date:11/14/2016)... SARASOTA, Fla., Nov. 14, 2016  xG Technology, Inc. ... in providing critical wireless communications for use in challenging ... ended September 30, 2016. Management will hold a conference ... at 5:00 p.m. Eastern Time (details below). ... announced a $16 million binding agreement to acquire Vislink ...
Breaking Biology News(10 mins):